Global Allergic Rhinitis Market Research Report—Forecast till 2025

Global Allergic Rhinitis Market: Information by Type (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), Treatment (Antihistamines, Corticosteroids, Immunotherapy, Decongestants and others), Route of Administration (Oral, Nasal and others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Stores) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025

Market Analysis
Allergic Rhinitis Market is expected to register a CAGR of 3.10% to reach USD 15064.12 Million by the year 2025. The Global Allergic Rhinitis Market is projected to expose profitable growth during the forecast period. Some of the significant factors characterizing the market growth are the increasing incidence of allergic rhinitis and increasing government initiatives to spread awareness about allergic diseases. However, the side-effects related usage of Allergic Rhinitis is anticipated to limit market growth over the forecast period. Allergic rhinitis, also known as hay fever, is an allergic disease associated with the nose. The allergic rhinitis affects when the immune system of the human body becomes clarified and overreacts to specific allergens in the environment, which are generally not harmful to most of the people. Allergic rhinitis may be classified as three different types viz., seasonal, perennial, and occupational. The increasing prevalence of allergic rhinitis, increasing government initiatives to promote awareness regarding allergic rhinitis, and growing healthcare expenditure and expansion of the private healthcare system is likely to drive the growth of the global allergic rhinitis market during the forecast period. For instance, according to the European Academy of Allergy and Clinical Immunology (EAACI), stated that over 150 million Europeans suffer from chronic allergic disease, out of which 100 million Europeans suffer from allergic rhinitis.

Market Segmentation
By type the Global Allergic Rhinitis Market has been segmented into Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis and Occupational Allergic Rhinitis. The antihistamines segment held a share of 40.4% in 2018. By Treatment the Global Allergic Rhinitis Market has been divided into Antihistamines, orticosteroids, Decongestants, Immunotherapy, Intranasal Anticholinergicsa and Others. By Route of Administration the global allergic rhinitis market has been segmented into Nasal, Oral and Others. Based on distribution channel the Global Allergic Rhinitis Market has been segmented into Retail Pharmacies, Hospital Pharmacies and Online Stores. Global Allergic Rhinitis Market into different regions like Americas broken into North America & Latin America. North America is sub-divided into US & Canada. Europe is split into the Western Europe and Eastern Europe. Western Europe is sub-divided into Germany, UK, France, Italy, Spain and Rest of Western Europe. Asia-Pacific including Japan, China, India, Australia, South Korea and Rest of Asia-Pacific, Middle East & Africa.

Regional Analysis
Geographically, the global allergic rhinitis market has been segmented into regions like Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas dominates the global allergic rhinitis market owing to the presence of major market players in the region, strategic acquisitions by major players to augment product portfolio, growing cases of respiratory disorders, and availability of advanced medications for the treatment of allergic rhinitis. For the instance, the National Centre for Biotechnology Information (NCBI) stated that the prevalence of allergic rhinitis in the US is approximately 15%, which are physician-diagnosed. The European region holds the second-largest market share owing to the adoption of advanced processing by hospitals and patients in the European countries, and ongoing efforts made by Global Allergy and Asthma European Network to strengthen European research, spread excellence. Asia-Pacific are estimated to be the fastest-growing region in the global market due to the continuous developments in developing countries like India and China. Emerging economies are expected to explain maximum cases of allergic rhinitis due to tobacco smoke, exposure to air pollutants in the home and workplace, vehicular pollution, and indoor air pollution, this is likely to drive the growth of the market. This region is expected to grow at a CAGR of 3.65% during the forecast period of 2019 to 2025. The allergic rhinitis market in the Middle East & Africa is expected to witness a modest market growth rate from the year 2019 to 2025. The established countries in the Middle East, such as the UAE and Saudi Arabia are the ones with the maximum share in the allergic rhinitis market. The advanced healthcare infrastructure boosted healthcare expenditure and growing per capita disposable incomes of the people in these countries are some factors contributing to their large share of the market in this region.

Major Players

AstraZeneca, GlaxoSmithKline plc, Johnson & Johnson Services, Inc, Bayer AG, Sanofi, Boehringer Ingelheim, Merck & Co., ALK-Abelló A/S, Novartis AG, Meda Pharmaceuticals, and others are some of the prominent players in the Global Allergic Rhinitis Market. Some of the projected onlookers for the Global Allergic Rhinitis Market are Allergic rhinitis drugs manufacturing companies, Research & development organizations and Academic institutes.
 


1 EXECUTIVE SUMMARY
1.1 MARKET SYNOPSIS 14

1.2 KEY CONTRIBUTING FACTORS 15

2 Market Introduction
2.1 DEFINITION 16

2.2 SCOPE OF THE STUDY 16

2.3 RESEARCH OBJECTIVE 16

2.4 MARKET STRUCTURE 17

2.5 ASSUMPTIONS & LIMITATIONS 17

3 RESEARCH METHODOLOGY
3.1 DATA MINING 18

3.2 SECONDARY RESEARCH 19

3.3 PRIMARY RESEARCH 20

3.3.1 BREAKDOWN OF PRIMARY RESPONDENTS 21

3.4 FORECASTING TECHNIQUES 22

3.5 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 23

3.5.1 BOTTOM-UP APPROACH 24

3.5.2 TOP-DOWN APPROACH 24

3.5.3 DATA TRIANGULATION 25

3.5.4 VALIDATION 25

4 MARKET DYNAMICS
4.1 INTRODUCTION 26

4.2 DRIVERS 27

4.2.1 RISING PREVALENCE OF ALLERGIC RHINITIS 27

4.2.2 GOVERNMENT INITIATIVES TO CREATE AWARENESS 27

4.2.3 INCREASING HEALTHCARE EXPENDITURE 27

4.3 RESTRAINTS 28

4.3.1 PATENT EXPIRY 28

4.3.2 SIDE EFFECTS OF TREATMENT FOR ALLERGIC RHINITIS 28

4.4 OPPORTUNITIES 28

4.4.1 INCREASING DEMAND IN DEVELOPING COUNTRIES 28

4.4.2 MORE ADVANCED PRODUCTS 28

5 MARKET FACTOR ANALYSIS
5.1 PORTER’S FIVE FORCES MODEL 29

5.1.1 BARGAINING POWER OF SUPPLIERS 30

5.1.2 BARGAINING POWER OF BUYERS 30

5.1.3 THREAT OF NEW ENTRANTS 30

5.1.4 THREAT OF SUBSTITUTES 30

5.1.5 INTENSITY OF RIVALRY 30

5.2 VALUE CHAIN ANALYSIS 31

5.2.1 R&D 32

5.2.2 MANUFACTURING 32

5.2.3 DISTRIBUTION & SALES 32

5.2.4 POST-SALES MONITORING 32

6 GLOBAL ALLERGIC RHINITIS MARKET BY TYPE
6.1 OVERVIEW 33

6.2 SEASONAL ALLERGIC RHINITIS 34

6.3 PERENNIAL ALLERGIC RHINITIS 34

6.4 OCCUPATIONAL ALLERGIC RHINITIS 35

7 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT
7.1 INTRODUCTION 36

7.2 ANTIHISTAMINES 37

7.3 CORTICOSTEROIDS 37

7.4 DECONGESTANTS 38

7.5 IMMUNOTHERAPY 38

7.6 INTRANASAL ANTICHOLINERGICS 38

7.7 OTHERS 39

8 GLOBAL ALLERGIC RHINITIS MARKET BY ROUTE OF ADMINISTRATION
8.1 OVERVIEW 40

8.2 NASAL 41

8.3 ORAL 41

8.4 OTHERS 42

9 GLOBAL ALLERGIC RHINITIS MARKET BY DISTRIBUTION CHANNEL
9.1 OVERVIEW 43

9.2 RETAIL PHARMACIES 44

9.3 HOSPITAL PHARMACIES 44

9.4 ONLINE STORES 45

10 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION
10.1 INTRODUCTION 46

10.2 AMERICAS 48

10.2.1 NORTH AMERICA 50

10.2.2 LATIN AMERICA 54

10.3 EUROPE 64

10.4 ASIA-PACIFIC 78

10.5 MIDDLE EAST & AFRICA 90

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 95

12 COMPANY PROFILES
12.1 ASTRAZENECA 97

12.1.1 COMPANY OVERVIEW 97

12.1.2 FINANCIAL OVERVIEW 97

12.1.3 PRODUCTS/SERVICES OFFERED 98

12.1.4 KEY DEVELOPMENTS 98

12.1.5 SWOT ANALYSIS 99

12.1.6 KEY STRATEGIES 99

12.2 BOEHRINGER INGELHEIM 100

12.2.1 COMPANY OVERVIEW 100

12.2.2 FINANCIAL OVERVIEW 100

12.2.3 PRODUCTS/SERVICES OFFERED 101

12.2.4 KEY DEVELOPMENTS 101

12.2.5 SWOT ANALYSIS 102

12.2.6 KEY STRATEGIES 102

12.3 MERCK & CO., INC. 103

12.3.1 COMPANY OVERVIEW 103

12.3.2 FINANCIAL OVERVIEW 103

12.3.3 PRODUCTS/SERVICES OFFERED 104

12.3.4 KEY DEVELOPMENTS 104

12.3.5 SWOT ANALYSIS 105

12.3.6 KEY STRATEGIES 105

12.4 GLAXOSMITHKLINE PLC 106

12.4.1 COMPANY OVERVIEW 106

12.4.2 FINANCIAL OVERVIEW 106

12.4.3 PRODUCTS/SERVICES OFFERED 107

12.4.4 KEY DEVELOPMENTS 107

12.4.5 SWOT ANALYSIS 108

12.4.6 KEY STRATEGIES 108

12.5 JOHNSON & JOHNSON SERVICES, INC. 109

12.5.1 COMPANY OVERVIEW 109

12.5.2 FINANCIAL OVERVIEW 109

12.5.3 PRODUCTS/SERVICES OFFERED 110

12.5.4 KEY DEVELOPMENTS 110

12.5.5 SWOT ANALYSIS 111

12.5.6 KEY STRATEGIES 111

12.6 BAYER AG 112

12.6.1 COMPANY OVERVIEWS 112

12.6.2 FINANCIAL OVERVIEW 112

12.6.3 PRODUCTS/SERVICES OFFERED 113

12.6.4 KEY DEVELOPMENTS 113

12.6.5 SWOT ANALYSIS 114

12.6.6 KEY STRATEGIES 114

12.7 ALK-ABELLÓ A/S 115

12.7.1 COMPANY OVERVIEW 115

12.7.2 FINANCIAL OVERVIEW 115

12.7.3 PRODUCTS/SERVICES OFFERED 116

12.7.4 KEY DEVELOPMENTS 116

12.7.5 SWOT ANALYSIS 117

12.7.6 KEY STRATEGIES 117

12.8 MEDA PHARMACEUTICALS 118

12.8.1 COMPANY OVERVIEW 118

12.8.2 FINANCIAL OVERVIEW 118

12.8.3 PRODUCTS/SERVICES OFFERED 119

12.8.4 KEY DEVELOPMENTS 119

12.8.5 SWOT ANALYSIS 120

12.8.6 KEY STRATEGIES 120

12.9 SANOFI 121

12.9.1 COMPANY OVERVIEW 121

12.9.2 FINANCIAL OVERVIEW 121

12.9.3 PRODUCTS/SERVICES OFFERED 122

12.9.4 KEY DEVELOPMENTS 122

12.9.5 SWOT ANALYSIS 123

12.9.6 KEY STRATEGIES 123

12.10 NOVARTIS AG 124

12.10.1 COMPANY OVERVIEW 124

12.10.2 FINANCIAL OVERVIEW 124

12.10.3 PRODUCTS/SERVICES OFFERED 125

12.10.4 KEY DEVELOPMENTS 125

12.10.5 SWOT ANALYSIS 126

12.10.6 KEY STRATEGIES 126

13 APPENDIX
13.1 REFERENCES 127

13.2 RELATED REPORTS 127
















































 


List Of Tables


TABLE 1 LIST OF ASSUMPTIONS 17

TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 21

TABLE 3 GLOBAL ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 34

TABLE 4 GLOBAL ALLERGIC RHINITIS MARKET FOR SEASONAL ALLERGIC RHINITIS, BY REGION, 2016–2025 (USD MILLION) 34

TABLE 5 GLOBAL ALLERGIC RHINITIS MARKET FOR PERENNIAL ALLERGIC RHINITIS, BY REGION, 2016–2025 (USD MILLION) 34

TABLE 6 GLOBAL ALLERGIC RHINITIS MARKET FOR OCCUPATIONAL ALLERGIC RHINITIS, BY REGION, 2016–2025 (USD MILLION) 35

TABLE 7 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 37

TABLE 8 GLOBAL ALLERGIC RHINITIS MARKET FOR ANTIHISTAMINES, BY REGION, 2016–2025 (USD MILLION) 37

TABLE 9 GLOBAL ALLERGIC RHINITIS MARKET FOR CORTICOSTEROIDS, BY REGION, 2016–2025 (USD MILLION) 37

TABLE 10 GLOBAL ALLERGIC RHINITIS MARKET FOR DECONGESTANTS, BY REGION, 2016–2025 (USD MILLION) 38

TABLE 11 GLOBAL ALLERGIC RHINITIS MARKET FOR IMMUNOTHERAPY, BY REGION, 2016–2025 (USD MILLION) 38

TABLE 12 GLOBAL ALLERGIC RHINITIS MARKET FOR INTRANASAL ANTICHOLINERGICS, BY REGION, 2016–2025 (USD MILLION) 38

TABLE 13 GLOBAL ALLERGIC RHINITIS MARKET FOR OTHER TREATMENTS, BY REGION, 2016–2025 (USD MILLION) 39

TABLE 14 GLOBAL ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 41

TABLE 15 GLOBAL ALLERGIC RHINITIS MARKET FOR NASAL, BY REGION, 2016–2025 (USD MILLION) 41

TABLE 16 GLOBAL ALLERGIC RHINITIS MARKET FOR ORAL, BY REGION, 2016–2025 (USD MILLION) 41

TABLE 17 GLOBAL ALLERGIC RHINITIS MARKET FOR OTHER ROUTE OF ADMINISTRATION, BY REGION, 2016–2025 (USD MILLION) 42

TABLE 18 GLOBAL ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 44

TABLE 19 GLOBAL ALLERGIC RHINITIS MARKET FOR RETAIL PHARMACIES, BY REGION, 2016–2025 (USD MILLION) 44

TABLE 20 GLOBAL ALLERGIC RHINITIS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2016–2025 (USD MILLION) 44

TABLE 21 GLOBAL ALLERGIC RHINITIS MARKET FOR ONLINE STORES, BY REGION, 2016–2025 (USD MILLION) 45

TABLE 22 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, 2016–2025 (USD MILLION) 47

TABLE 23 AMERICAS: ALLERGIC RHINITIS MARKET, BY REGION, 2016–2025 (USD MILLION) 48

TABLE 24 AMERICAS: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 48

TABLE 25 AMERICAS: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 49

TABLE 26 AMERICAS: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 49

TABLE 27 AMERICAS: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 49

TABLE 28 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 50

TABLE 29 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 50

TABLE 30 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 51

TABLE 31 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 51

TABLE 32 NORTH AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 51

TABLE 33 US: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 52

TABLE 34 US: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 52

TABLE 35 US: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 52

TABLE 36 US: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 53

TABLE 37 CANADA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 53

TABLE 38 CANADA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 53

TABLE 39 CANADA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 54

TABLE 40 CANADA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 54

TABLE 41 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 55

TABLE 42 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 55

TABLE 43 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 55

TABLE 44 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 56

TABLE 45 LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 56

TABLE 46 BRAZIL: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 56

TABLE 47 BRAZIL: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 57

TABLE 48 BRAZIL: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 57

TABLE 49 BRAZIL: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 57

TABLE 50 ARGENTINA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 58

TABLE 51 ARGENTINA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 58

TABLE 52 ARGENTINA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 58

TABLE 53 ARGENTINA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 59

TABLE 54 COLUMBIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 59

TABLE 55 COLUMBIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 59

TABLE 56 COLUMBIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 60

TABLE 57 COLUMBIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 60

TABLE 58 CHILE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 60

TABLE 59 CHILE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 61

TABLE 60 CHILE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 61

TABLE 61 CHILE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 61

TABLE 62 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 62

TABLE 63 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 62

TABLE 64 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 62

TABLE 65 REST OF LATIN AMERICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 63

TABLE 66 EUROPE: ALLERGIC RHINITIS MARKET, BY REGION, 2016–2025 (USD MILLION) 64

TABLE 67 EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 64

TABLE 68 EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 65

TABLE 69 EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 65

TABLE 70 EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 65

TABLE 71 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 66

TABLE 72 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 66

TABLE 73 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 67

TABLE 74 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 67

TABLE 75 WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 67

TABLE 76 GERMANY: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 68

TABLE 77 GERMANY: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 68

TABLE 78 GERMANY: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 68

TABLE 79 GERMANY: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 69

TABLE 80 FRANCE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 69

TABLE 81 FRANCE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 69

TABLE 82 FRANCE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 70

TABLE 83 FRANCE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 70

TABLE 84 UK: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 70

TABLE 85 UK: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 71

TABLE 86 UK: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 71

TABLE 87 UK: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 71

TABLE 88 ITALY: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 72

TABLE 89 ITALY: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 72

TABLE 90 ITALY: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 72

TABLE 91 ITALY: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 73

TABLE 92 SPAIN: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 73

TABLE 93 SPAIN: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 73

TABLE 94 SPAIN: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 74

TABLE 95 SPAIN: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 74

TABLE 96 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 74

TABLE 97 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 75

TABLE 98 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 75

TABLE 99 REST OF WESTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 75

TABLE 100 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 76

TABLE 101 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 76

TABLE 102 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 76

TABLE 103 EASTERN EUROPE: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 77

TABLE 104 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY COUNTRY, 2016–2025 (USD MILLION) 78

TABLE 105 SIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 79

TABLE 106 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 79

TABLE 107 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 79

TABLE 108 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 80

TABLE 109 JAPAN: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 80

TABLE 110 JAPAN: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 80

TABLE 111 JAPAN: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 81

TABLE 112 JAPAN: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 81

TABLE 113 CHINA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 81

TABLE 114 CHINA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 82

TABLE 115 CHINA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 82

TABLE 116 CHINA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 82

TABLE 117 INDIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 83

TABLE 118 INDIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 83

TABLE 119 INDIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 83

TABLE 120 INDIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 84

TABLE 121 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 84

TABLE 122 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 84

TABLE 123 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 85

TABLE 124 AUSTRALIA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 85

TABLE 125 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 85

TABLE 126 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 86

TABLE 127 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 86

TABLE 128 SOUTH KOREA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 86

TABLE 129 THAILAND: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 87

TABLE 130 THAILAND: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 87

TABLE 131 THAILAND: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 87

TABLE 132 THAILAND: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 88

TABLE 133 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 88

TABLE 134 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 88

TABLE 135 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 89

TABLE 136 REST OF ASIA-PACIFIC: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 89

TABLE 137 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY REGION, 2016–2025 (USD MILLION) 90

TABLE 138 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 90

TABLE 139 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 91

TABLE 140 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 91

TABLE 141 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 91

TABLE 142 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 92

TABLE 143 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 92

TABLE 144 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 92

TABLE 145 MIDDLE EAST: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 93

TABLE 146 AFRICA: ALLERGIC RHINITIS MARKET, BY TYPE, 2016–2025 (USD MILLION) 93

TABLE 147 AFRICA: ALLERGIC RHINITIS MARKET, BY TREATMENT, 2016–2025 (USD MILLION) 93

TABLE 148 AFRICA: ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2016–2025 (USD MILLION) 94

TABLE 149 AFRICA: ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2016–2025 (USD MILLION) 94

TABLE 150 ASTRAZENECA: PRODUCTS/SERVICES OFFERED 98

TABLE 151 ASTRAZENECA: KEY DEVELOPMENTS 98

TABLE 152 BOEHRINGER INGELHEIM: PRODUCTS/SERVICES OFFERED 101

TABLE 153 BOEHRINGER INGELHEIM: KEY DEVELOPMENTS 101

TABLE 154 MERCK & CO., INC.: PRODUCTS/SERVICES OFFERED 104

TABLE 155 MERCK & CO., INC: KEY DEVELOPMENTS 104

TABLE 156 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED 107

TABLE 157 GLAXOSMITHKLINE PLC: KEY DEVELOPMENTS 107

TABLE 158 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS/SERVICES OFFERED 110

TABLE 159 BAYER AG: PRODUCTS/SERVICES OFFERED 113

TABLE 160 BAYER AG: KEY DEVELOPMENTS 113

TABLE 161 ALK-ABELLÓ A/S: PRODUCTS/SERVICES OFFERED 116

TABLE 162 ALK-ABELLÓ A/S: KEY DEVELOPMENTS 116

TABLE 163 MEDA PHARMACEUTICALS: PRODUCTS/SERVICES OFFERED 119

TABLE 164 MEDA PHARMACEUTICALS: KEY DEVELOPMENTS 119

TABLE 165 SANOFI: PRODUCTS/SERVICES OFFERED 122

TABLE 166 NOVARTIS AG: PRODUCTS/SERVICES OFFERED 125

 


List Of Figures


FIGURE 1 MARKET SYNOPSIS 14

FIGURE 2 GLOBAL ALLERGIC RHINITIS MARKET: STRUCTURE 17

FIGURE 3 BOTTOM-UP AND TOP-DOWN APPROACHES 23

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ALLERGIC RHINITIS MARKET 26

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ALLERGIC RHINITIS MARKET 29

FIGURE 6 VALUE CHAIN ANALYSIS OF THE GLOBAL ALLERGIC RHINITIS MARKET 31

FIGURE 7 GLOBAL ALLERGIC RHINITIS MARKET, BY TYPE, 2018 & 2025 (USD MILLION) 33

FIGURE 8 GLOBAL ALLERGIC RHINITIS MARKET, BY TREATMENT, 2018 & 2025 (USD MILLION) 36

FIGURE 9 GLOBAL ALLERGIC RHINITIS MARKET, BY ROUTE OF ADMINISTRATION, 2018 & 2025 (USD MILLION) 40

FIGURE 10 GLOBAL ALLERGIC RHINITIS MARKET, BY DISTRIBUTION CHANNEL, 2018 & 2025 (USD MILLION) 43

FIGURE 11 GLOBAL ALLERGIC RHINITIS MARKET, BY REGION, 2018 & 2025 (USD MILLION) 47

FIGURE 12 AMERICAS: ALLERGIC RHINITIS MARKET SHARE, BY REGION 2018 (%) 48

FIGURE 13 NORTH AMERICA: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY 2018 (%) 50

FIGURE 14 LATIN AMERICA: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY 2018 (%) 54

FIGURE 15 EUROPE: ALLERGIC RHINITIS MARKET SHARE, BY REGION, 2018 (%) 64

FIGURE 16 WESTERN EUROPE: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY, 2018 (%) 66

FIGURE 17 ASIA-PACIFIC: ALLERGIC RHINITIS MARKET SHARE, BY COUNTRY, 2018 (%) 78

FIGURE 18 MIDDLE EAST & AFRICA: ALLERGIC RHINITIS MARKET SHARE, BY REGION, 2018 (%) 90

FIGURE 19 GLOBAL ALLERGIC RHINITIS MARKET, MARKET SHARE ANALYSIS 2018 (% SHARE) 95

FIGURE 20 ASTRAZENECA: FINANCIAL OVERVIEW SNAPSHOT 97

FIGURE 21 ASTRAZENECA: SWOT ANALYSIS 99

FIGURE 22 BOEHRINGER INGELHEIM: FINANCIAL OVERVIEW 100

FIGURE 23 BOEHRINGER INGELHEIM: SWOT ANALYSIS 102

FIGURE 24 MERCK & CO., INC.: FINANCIAL OVERVIEW SNAPSHOT 103

FIGURE 25 MERCK & CO., INC.: SWOT ANALYSIS 105

FIGURE 26 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT 106

FIGURE 27 GLAXOSMITHKLINE PLC.: SWOT ANALYSIS 108

FIGURE 28 JOHNSON & JOHNSON SERVICES, INC.: FINANCIAL OVERVIEW SNAPSHOT 109

FIGURE 29 JOHNSON & JOHNSON SERVICES, INC.: SWOT ANALYSIS 111

FIGURE 30 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 112

FIGURE 31 BAYER AG: SWOT ANALYSIS 114

FIGURE 32 ALK-ABELLÓ A/S FINANCIAL OVERVIEW SNAPSHOT 115

FIGURE 33 ALK-ABELLÓ A/S: SWOT ANALYSIS 117

FIGURE 34 MEDA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT 118

FIGURE 35 MEDA PHARMACEUTICALS: SWOT ANALYSIS 120

FIGURE 36 SANOFI: FINANCIAL OVERVIEW SNAPSHOT 121

FIGURE 37 SANOFI: SWOT ANALYSIS 123

FIGURE 38 NOVARTIS AG: FINANCIAL OVERVIEW SNAPSHOT 124

FIGURE 39 NOVARTIS AG: SWOT ANALYSIS 126
 


Allergic Rhinitis - Pipeline Review, H1 2020

Allergic Rhinitis - Pipeline Review, H1 2020 latest Pharmaceutical and Healthcare disease pipeline guide Allergic Rhinitis - Pipeline Review, H1 2020, provides an overview of the Allergic Rhinitis (Respiratory) pipeline

USD 2000 View Report

COVID-19 Outbreak-Global Allergic Conjunctivitis Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020

Allergic conjunctivitis is an inflammation of the eye caused by an allergic reaction to substances such as pollen or mold spores.The Allergic Conjunctivitis market revenue was xx.xx Million USD in

USD 3660 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available